Alec Deichman

Alec Deichman serves as the primary procurement lead for the Medical Supply Chain Pharmacy FSA under the Department of Defense’s DLA Troop Support, responsible for ensuring the secure, timely acquisition of mission-critical pharmaceuticals and medical formulations to sustain global troop readiness. He manages a diverse portfolio of contracts spanning pharmaceutical manufacturing, wholesale distribution, and specialized topical preparations, with a focus on maintaining supply chain resilience across austere and deployed environments. His acquisitions encompass injectables, oral solid dosage forms, antiparasitic creams, and anesthetics, all aligned with military medical standards and regulatory compliance requirements. Deichman’s work directly supports the agency’s mission to guarantee uninterrupted access to life-saving medications for U.S. military personnel worldwide. Deichman collaborates with a broad network of pharmaceutical manufacturers and merchant wholesalers, engaging primarily with firms capable of meeting stringent DoD quality, traceability, and cold-chain logistics standards. While no single contractor dominates his portfolio, he consistently works with vendors possessing cGMP certification, FDA-registered facilities, and validated distribution networks. His contracting approach emphasizes performance-based requirements, lifecycle sustainment, and contingency planning to mitigate supply disruptions in high-risk operational theaters. Deichman’s procurement strategy reflects a strong preference for open competition, with 100% of his acquisitions classified as “No Set-Aside.” This reflects the critical nature of pharmaceutical supply continuity, where speed, scale, and regulatory compliance often outweigh socioeconomic targeting. While small business participation is not formally prioritized through set-asides, he maintains flexibility to consider qualified small businesses when their capabilities align with technical and operational demands. His core industry focus lies in NAICS 325412 (Pharmaceutical Preparation Manufacturing), accounting for 73.3% of his activity, followed by 424210 (Drugs and Druggists’ Sundries Merchant Wholesalers) and 325620 (Toilet Preparation Manufacturing). He specializes in procuring sterile injectables, oral tablets, and topical formulations with strict shelf-life and storage requirements, demonstrating deep technical expertise in pharmaceutical logistics, batch traceability, and DoD-specific medical materiel standards.